|
1
|
Donohue JH, Stewart AK and Menck HR: The
National Cancer Data Base report on carcinoma of the gallbladder,
1989–1995. Cancer. 83:2618–2628. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. 2013 CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Randi G, Malvezzi M, Levi F, et al:
Epidemiology of biliary tract cancers: an update. Ann Oncol.
20:146–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du Q, Jiang L, Wang XQ, Pan W, She FF and
Chen YL: Establishment of and comparison between orthotopic
xenograft and subcutaneous xenograft models of gallbladder
carcinoma. Asian Pac J Cancer Prev. 15:3747–3752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wernberg JA and Lucarelli DD: Gallbladder
cancer. Surg Clin North Am. 94:343–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Albores-Saavedra J, Alcantra-Vazquez A,
Cruz-Ortiz H and Herrera-Goepfert R: The precursor lesions of
invasive gallbladder carcinoma Hyperplasia, atypical hyperplasia
and carcinoma in situ. Cancer. 45:919–927. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jankun J, Selman SH, Swiercz R and
Skrzypczak-Jankun E: Why drinking green tea could prevent cancer.
Nature. 387:5611997. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reto M, Figueira ME, Filipe HM and Almeida
CM: Chemical composition of green tea (Camellia sinensis)
infusions commercialized in Portugal. Plant Foods Hum Nutr.
62:139–144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jochmann N, Baumann G and Stangl V: Green
tea and cardiovascular disease: from molecular targets towards
human health. Curr Opin Clin Nutr Metab Care. 11:758–765. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng S, Ding L, Zhen Y, et al: Progress
in studies on the antimutagenicity and anticarcinogenicity of green
tea epicatechins. Chin Med Sci J. 6:233–238. 1991.PubMed/NCBI
|
|
11
|
Gupta S, Saha B and Giri AK: Comparative
antimutagenic and anticlastogenic effects of green tea and black
tea: a review. Mutat Res. 512:37–65. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lambert JD and Elias RJ: The antioxidant
and pro-oxidant activities of green tea polyphenols: a role in
cancer prevention. Arch Biochem Biophys. 501:65–72. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cabrera C, Artacho R and Gimenez R:
Beneficial effects of green tea - a review. J Am Coll Nutr.
25:79–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lian CQ, Zhang J and Chen ZD: Changes of
free calcium ion concentration and mitochondrial membrane potential
during apoptosis of human gallbladder carcinoma GBC-SD cells
induced by tea polyphenols. Chin J Biol. 25:449–452. 2012.
|
|
15
|
Lian CQ, Xia J, Gao Q and Zhang J: A study
on apoptosis in human gallbladder carcinoma GBC-SD cells induced by
tea polyphenols. Chin J Gerontol. 32:2077–2080. 2012.
|
|
16
|
Nechuta S, Shu XO, Li HL, et al:
Prospective cohort study of tea consumption and risk of digestive
system cancers: results from the Shanghai Women's Health Study. Am
J Clin Nutr. 96:1056–1063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yen S, Hsieh CC and MacMahon B:
Extrahepatic bile duct cancer and smoking, beverage consumption,
past medical history, and oral contraceptive use. Cancer.
59:2112–2116. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagano J, Kono S, Preston DL and Mabuchi
K: A prospective study of green tea consumption and cancer
incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control.
12:501–508. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang XH, Andreotti G, Gao YT, et al: Tea
drinking and the risk of biliary tract cancers and biliary stones:
a population-based case-control study in Shanghai, China. Int J
Cancer. 118:3089–3094. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zatonski WA, La Vecchia C, Przewozniak K,
Maisonneuve P, Lowenfels AB and Boyle P: Risk factors for
gallbladder cancer: a Polish case-control study. Int J Cancer.
51:707–711. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
La Vecchia C, Negri E, Franceschi S,
D'Avanzo B and Boyle P: Tea consumption and cancer risk. Nutr
Cancer. 17:27–31. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pandey M and Shukla VK: Diet and
gallbladder cancer: a case-control study. Eur J Cancer Prev.
11:365–368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XH, Gao YT, Rashid A, et al: Tea
consumption and risk of biliary tract cancers and gallstone
disease: a population-based case-control study in Shanghai, China.
Chin J Oncol. 27:667–671. 2005.(In Chinese).
|
|
26
|
Yang CS, Maliakal P and Meng X: Inhibition
of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 42:25–54.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen D, Daniel KG, Kuhn DJ, et al: Green
tea and tea polyphenols in cancer prevention. Front Biosci.
9:2618–2631. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huo C, Wan SB, Lam WH, et al: The
challenge of developing green tea polyphenols as therapeutic
agents. Inflammopharmacology. 16:248–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Adhami VM, Siddiqui IA, Sarfaraz S, et al:
Effective prostate cancer chemopreventive intervention with green
tea polyphenols in the TRAMP model depends on the stage of the
disease. Clin Cancer Res. 15:1947–1953. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bettuzzi S, Rizzi F and Belloni L:
Clinical relevance of the inhibitory effect of green tea catechins
(GtCs) on prostate cancer progression in combination with molecular
profiling of catechin-resistant tumors: an integrated view. Pol J
Vet Sci. 10:57–60. 2007.PubMed/NCBI
|
|
31
|
Scaltriti M, Belloni L, Caporali A, et al:
Molecular classification of green tea catechin-sensitive and green
tea catechin-resistant prostate cancer in the TRAMP mice model by
quantitative real-time PCR gene profiling. Carcinogenesis.
27:1047–1053. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inoue M, Tajima K, Mizutani M, et al:
Regular consumption of green tea and the risk of breast cancer
recurrence: follow-up study from the Hospital-based Epidemiologic
Research Program at Aichi Cancer Center (HERPACC). Japan. Cancer
Lett. 167:175–182. 2001. View Article : Google Scholar
|
|
33
|
Wu AH, Yu MC, Tseng CC, Hankin J and Pike
MC: Green tea and risk of breast cancer in Asian Americans. Int J
Cancer. 106:574–579. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arts IC, . A review of the epidemiological
evidence on tea, flavonoids, and lung cancer. J Nutr.
138:1561S–1566S. 2008.PubMed/NCBI
|
|
35
|
De Stefani E, Fierro L, Mendilaharsu M, et
al: Meat intake, ‘mate’ drinking and renal cell cancer in Uruguay:
a case-control study. Br J Cancer. 78:1239–1243. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu J, Mao Y, DesMeules M, Csizmadi I,
Friedenreich C and Mery L: Canadian Cancer Registries Epidemiology
Research Group: Total fluid and specific beverage intake and risk
of renal cell carcinoma in Canada. Cancer Epidemiol. 33:355–362.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhong S, Chen Z, Yu X, et al: Tea
consumption and leukemia risk: a meta-analysis. Tumour Biol.
35:5205–5212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu ZH, Lin YW, Xu X, et al: No association
between tea consumption and risk of renal cell carcinoma: a
meta-analysis of epidemiological studies. Asian Pac J Cancer Prev.
14:1691–1695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin YW, Hu ZH, Wang X, et al: Tea
consumption and prostate cancer: an updated meta-analysis. World J
Surg Oncol. 12:382014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Myung SK, Bae WK, Oh SM, et al: Green tea
consumption and risk of stomach cancer: a meta-analysis of
epidemiologic studies. Int J Cancer. 124:670–677. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yuan JM, Sun C and Butler LM: Tea and
cancer prevention: epidemiological studies. Pharmacol Res.
64:123–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai
Q and Fraumeni JF Jr: Reduced risk of esophageal cancer associated
with green tea consumption. J Natl Cancer Inst. 86:855–858. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pandey M and Shukla VK: Lifestyle, parity,
menstrual and reproductive factors and risk of gallbladder cancer.
Eur J Cancer Prev. 12:269–272. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakagaki M and Nakayama F: Effect of
female sex hormones on lithogenicity of bile. Jpn J Surg. 12:13–18.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen A and Huminer D: The role of estrogen
receptors in the development of gallstones and gallbladder cancer.
Med Hypotheses. 36:259–260. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kuruto-Niwa R, Inoue S, Ogawa S, Muramatsu
M and Nozawa R: Effects of tea catechins on the ERE-regulated
estrogenic activity. J Agric Food Chem. 48:6355–6361. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nagai M, Conney AH and Zhu BT: Strong
inhibitory effects of common tea catechins and bioflavonoids on the
O-methylation of catechol estrogens catalyzed by human liver
cytosolic catechol-O-methyltransferase. Drug Metab Dispos.
32:497–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
